COLLEEN YOUNG: Open Payments
NPI 1104296805 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,639 in 148 payments from 18 companies in 2025. Trend: 2023 $2,080 · 2024 $2,372 · 2025 $2,639
Food & beverage: $2,629Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $608 |
| Janssen Biotech, Inc. | 19 | $379 |
| E.R. Squibb & Sons, L.L.C. | 8 | $343 |
| Novartis Pharmaceuticals Corporation | 14 | $245 |
| LEO Pharma Inc. | 9 | $183 |
| UCB, Inc. | 17 | $140 |
| Amgen Inc. | 8 | $139 |
| Lilly USA, LLC | 11 | $135 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $107 |
| GENZYME CORPORATION | 3 | $76 |
Products named: TREMFYA, SKYRIZI, Sotyktu, RINVOQ, Bimzelx, OTEZLA, COSENTYX, TALTZ.
Industry payments across KS — which companies pay providers there.
